Skip to main content
PepStack

Dihydrotestosterone

Sex Hormones & TRT
DHT5α-DihydrotestosteroneAndrostanoloneStanolone

Overview

Dihydrotestosterone (DHT), also known as 5α-Dihydrotestosterone or Androstanolone, is an endogenous androgen sex steroid and hormone. It is primarily produced in the gonads and adrenal glands through the conversion of testosterone by the enzyme 5α-reductase. DHT belongs to the class of androgens, which are a subset of steroid hormones. It is a potent androgen with a significant role in the development of male characteristics and is also present in females in smaller amounts. Researchers have found that DHT plays a crucial role in the development of male primary and secondary sexual characteristics, such as facial hair, deepening of the voice, and muscle growth. It is also involved in the pathophysiology of conditions like androgenetic alopecia and benign prostatic hyperplasia. Research areas include its role in prostate health, hair loss, and its potential therapeutic applications in hormone replacement therapy. DHT exerts its effects by binding to androgen receptors, which then translocate to the cell nucleus and modulate the expression of specific genes. This action initiates a cascade of biological processes that lead to the development of male characteristics and other androgenic effects. The pharmacokinetic properties of DHT include a circulating half-life of approximately 70 minutes. It is metabolized primarily in the liver and excreted in urine. The bioavailability of DHT varies depending on the route of administration, with oral bioavailability being poor due to first-pass metabolism. Clinically, DHT is used in certain hormone replacement therapies and has been studied for its effects on conditions like hypogonadism. Its use is regulated, and it is classified as a controlled substance in many countries due to its potent androgenic effects and potential for misuse.

Mechanism of Action

DHT acts primarily on androgen receptors, which are intracellular receptors that, upon binding with DHT, translocate to the nucleus and influence gene expression. This interaction leads to the activation of pathways that promote the development of male secondary sexual characteristics and other androgenic effects.

Molecular Data

FormulaC19H30O2
Molecular Weight290.4 g/mol
CAS Number521-18-6
PubChem CID10635

Half-Life & Pharmacokinetics

EndogenousCirculating half-life ~70 minutes
TransdermalSteady-state after 24-48h
OralPoor bioavailability due to first-pass

DHT is often administered in non-oral forms due to poor oral bioavailability.

Storage

Temperature

Store at room temperature (15-30°C)

Light

Protect from light

Form

Oil solution stable for 2+ years

Notes

Ensure container is tightly closed to prevent contamination.

Solubility

DHT is poorly soluble in water but soluble in ethanol and oils, which is relevant for its formulation in topical and injectable preparations.

Legal Status

🇩🇪DE

In Germany, DHT is a prescription-only medication (verschreibungspflichtig) and may be subject to controlled substance regulations.

🇺🇸US

In the USA, DHT is not FDA-approved for any indication and is classified as a Schedule III controlled substance under the DEA.

🇦🇺AU

In Australia, DHT is classified as a Schedule 4 (S4) prescription-only medicine.

🇬🇧UK

In the UK, DHT is classified as a prescription-only medicine (POM) and regulated by the MHRA.

Legal status information is provided for general reference only and may not reflect the most current regulatory changes. Always verify with official government sources before making any decisions.

8 Research Publications

Identification, structure, and agonist design of an androgen membrane receptor.

Unknown

Cell · 2025

Researchers found that the androgen 5α-dihydrotestosterone (5α-DHT) activates a membrane receptor called GPR133 in muscle cells, which increases levels of a molecule called cyclic AMP (cAMP) and enhances muscle strength. They also identified the structure of this receptor when bound to 5α-DHT, providing insights into how androgens are recognized by this receptor.

  • 5α-DHT activates the GPR133 receptor in muscle cells.
  • Activation of GPR133 increases cyclic AMP levels.
  • The structure of GPR133 bound to androgens was determined.
PubMed

Reduction of Prostate Cancer Risk: Role of Frequent Ejaculation-Associated Mechanisms.

Review

Cancers · 2025

Researchers observed that frequent ejaculation may help reduce the risk of prostate cancer by influencing hormonal mechanisms in the prostate. They suggest that regular ejaculation could be a potential preventive strategy against prostate cancer, alongside other known risk factors.

  • Prostate cancer accounts for about 15% of cancers diagnosed in men.
  • Ejaculation may regulate prostate health through hormonal interactions.
  • Frequent ejaculation, without risky sexual behaviors, could lower prostate cancer risk.
PubMed

Endocrine Disruptors and Prostate Cancer.

Review

International journal of molecular sciences · 2022

Researchers observed that endocrine disruptors (EDs) can negatively affect the prostate gland, which is crucial for male fertility. They found that these disruptors may influence the development and progression of prostate cancer by altering cellular pathways, particularly those related to androgen receptor signaling.

  • EDs can impact molecular mechanisms in the prostate gland.
  • Prostate cancer is linked to changes in androgen receptor signaling.
  • Altered regulation of cell growth may lead to prostate cancer onset and progression.
PubMed

Androgens in human breast carcinoma.

Review

Medical molecular morphology · 2010

Researchers observed that androgens, particularly a potent form called DHT, are present in higher concentrations in breast cancer tissues compared to blood. They found that androgens generally inhibit the growth of breast cancer cells, but the relationship between androgen receptors and patient outcomes is still unclear. Additionally, a specific type of breast cancer, known as molecular apocrine carcinoma, shows increased androgen signaling and unique characteristics.

  • DHT levels are higher in breast cancer tissue than in plasma.
  • Androgens mainly have growth-inhibiting effects on breast cancer cells.
  • Molecular apocrine breast carcinoma is characterized by being ER negative and AR positive.
PubMed

Pre-receptor regulation of the androgen receptor.

Review

Molecular and cellular endocrinology · 2008

Researchers observed that two specific enzymes in the prostate regulate the activity of the androgen receptor, which is important for male development and prostate health. One enzyme converts a potent androgen into an inactive form, while the other converts it back, suggesting potential targets for treating conditions related to androgen levels.

  • Type 3 3alpha-HSD converts 5alpha-dihydrotestosterone into an inactive form.
  • RoDH like 3alpha-HSD converts the inactive form back into the potent androgen.
  • These enzymes play a role in regulating androgen action in the prostate.
PubMed

Identification of the molecular switch that regulates access of 5alpha-DHT to the androgen receptor.

Review

Molecular and cellular endocrinology · 2007

Researchers found that specific enzymes, known as hydroxysteroid dehydrogenases (HSDs), act as molecular switches that control the availability of a potent hormone, 5alpha-DHT, to its receptor in the prostate. They identified two types of HSDs that either activate or deactivate this hormone, influencing how it affects the body.

  • HSDs regulate access to the androgen receptor in the prostate.
  • Type 3 3alpha-hydroxysteroid dehydrogenase converts 5alpha-DHT to an inactive form.
  • Another enzyme converts the inactive form back to 5alpha-DHT, controlling its effects.
PubMed

Complexities of androgen action.

Review

Journal of the American Academy of Dermatology · 2001

Researchers observed that androgens, like testosterone and DHT, play important roles in development and adult functions. They found that the effects of these hormones are mediated through a specific androgen receptor gene and involve various proteins that help regulate gene activity in different tissues and cell types.

  • Androgens are crucial for many biological processes in both embryos and adults.
  • The primary androgen receptor gene is located on the X-chromosome.
  • Different proteins influence how androgens regulate gene activity in various tissues.
PubMed

Dihydrotestosterone is a peripheral paracrine hormone.

Review

Journal of andrology · 1992

Researchers observed that dihydrotestosterone (DHT) acts primarily within specific tissues, like skin and the prostate, rather than being accurately reflected in blood levels. They found that a metabolite called 3 alpha androstanediol glucuronide is a better indicator of DHT formation in these tissues and can vary with conditions like hirsutism and acne.

  • DHT is mainly produced from testosterone and acts locally in target tissues.
  • Blood levels of DHT do not reliably indicate its production in the body.
  • 3 alpha androstanediol glucuronide is a key marker for DHT formation, especially in skin.
PubMed

Track your hormone research in PepStack

Log cycles, set reminders and visualize serum levels.

This page is for informational and research purposes only. All information is based on published scientific literature. Nothing on this page constitutes medical advice or replaces consultation with a qualified healthcare professional.